University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery ...

With data as of April 8, 2026, we examine if Anbio Biotechnology(NNNN) is consistently building momentum based on AAII's A+ ...

Strong participation in recent $33 million common stock offering highlights investor confidence in late-stage clinical momentum and commercial ...

The NASB head emphasized that the BNBC is truly a landmark project, during which new production facilities have been built and new technologies have been mastered.

Hello, I’m Ricki Lee, and this is The Capital Compass. Today we’re taking a look at Kraig Biocraft Laboratories (USOTC:KBLB), ...

At the same time, science continues to feed back into pop culture. Advances in genetics, epidemiology and AI provide new ...

China is pumping money into its biotech industry, helping launch a new wave of labs and incubators in the country. Experts say this could slow down American innovation in the biotech space. China's ...

Korean biotechnology company, Nature Cell, is planning to open a stem cell facility in Baltimore, bringing 500 new jobs, the governor announced Tuesday. The 100,000 square foot manufacturing facility ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Sana's allogeneic HIP technology achieved a first in T1D, showing insulin production and immune evasion without immunosuppression, but scalability remains unproven. Despite promising early data, Sana ...

One of the greatest transformations in modern medicine arguably began with a corned beef sandwich. It was the late 1960s, and new Department of Medicine Chair Lloyd Hollingsworth “Holly” Smith Jr., MD ...